Collaborative Innovation Center of Tumor Marker Detection Technology, Equipment and Diagnosis-Therapy Integration in Universities of Shandong, Shandong Provincial Key Laboratory of Detection Technology for Tumor Markers, College of Chemistry and Chemical Engineering, Linyi University, Linyi 276005, China.
College of Chemistry & Chemical Engineering, Central South University, Changsha, Hunan 410083, China.
Anal Chem. 2022 Mar 8;94(9):4072-4077. doi: 10.1021/acs.analchem.1c05643. Epub 2022 Feb 23.
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal interstitial pneumonia with unknown pathogenesis. Early diagnosis and therapeutic intervention are essential for improving the prognosis of patients with IPF. The level of nitric oxide upregulates in the alveoli of IPF patients, which is correlated with the severity of the disease. Herein, we report a fluorescent probe DCM-nitric oxide (NO) to detect IPF by monitoring the concentration changes of NO. This probe displays a fast response time and a good linear response to NO in vitro. Fluorescence imaging experiments with probe DCM-NO revealed that the level of intracellular NO increases in the pulmonary fibrosis cells and IPF mice models. Probe DCM-NO displayed a strong red fluorescence in IPF mice models. However, a declining fluorescence was evidenced in the OFEV-treated IPF mice, implying that DCM-NO is capable of evaluating the therapeutic effects on IPF. Thus, probe DCM-NO can quickly predict the progression of pulmonary fibrosis at an early stage and thus help improve the effective treatment.
特发性肺纤维化(IPF)是一种病因不明的慢性、进行性、致命性间质性肺炎。早期诊断和治疗干预对于改善 IPF 患者的预后至关重要。IPF 患者肺泡中的一氧化氮水平上调,与疾病的严重程度相关。在此,我们报告了一种荧光探针 DCM-NO,通过监测 NO 浓度的变化来检测 IPF。该探针在体外对 NO 具有快速的响应时间和良好的线性响应。使用探针 DCM-NO 进行的荧光成像实验表明,肺纤维化细胞和 IPF 小鼠模型中细胞内 NO 的水平增加。探针 DCM-NO 在 IPF 小鼠模型中显示出强烈的红色荧光。然而,在 OFEV 治疗的 IPF 小鼠中则表现出荧光强度降低,表明 DCM-NO 能够评估对 IPF 的治疗效果。因此,探针 DCM-NO 可以快速预测早期肺纤维化的进展,从而有助于改善有效治疗。